Location History:
- Merion, PA (US) (2015)
- Merion Station, PA (US) (2017 - 2020)
Company Filing History:
4 out of 2,597 
1 out of 282 
Years Active: 2015-2025
Title: The Innovative Contributions of Amos Smith
Introduction
Amos Smith is a notable inventor based in Merion Station, PA (US), recognized for his significant contributions to the field of neurodegenerative disorders. With a total of 4 patents, his work focuses on developing treatments that address critical health challenges.
Latest Patents
Among his latest patents, one includes "Oleic acid derivatives as treatments for Friedreich ataxia and inhibitors of ferroptosis." This invention relates to compounds of Formula I or Formula II, which are used in compositions and methods for treating neurodegenerative disorders, particularly Friedreich ataxia. Another significant patent is for "Small molecule activators of mitochondrial function." This patent describes methods for improving mitochondrial function, decreasing iron accumulation, and reducing oxidative stress. These methods are beneficial in treating diseases such as Friedreich's ataxia, normal aging, Alzheimer's disease, and Parkinson's disease.
Career Highlights
Amos Smith has worked with prestigious institutions, including the University of Pennsylvania and The Children's Hospital of Philadelphia. His research has led to advancements in understanding and treating mitochondrial diseases, showcasing his commitment to improving health outcomes.
Collaborations
Throughout his career, Amos has collaborated with esteemed colleagues, including Robert B. Wilson and Maria Grazia Cotticelli. These partnerships have further enriched his research and innovation efforts.
Conclusion
Amos Smith's contributions to the field of neurodegenerative disorders through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and understanding of complex diseases.